EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Detection in seized samples, analytical characterization, and in vitro metabolism of the newly emerged 5‐bromo‐indazole‐3‐carboxamide synthetic cannabinoid receptor agonists

Caitlyn Norman iD, Kristin Webling, Oleksandra Kyslychenko, Robert Reid, Alex J Krotulski, Ryan Farrell, Marie H Deventer, Huiling Liu, Matthew J Connolly, Claude Guillou iD, Inge M J Vinckier, Barry K Logan und 4 weitere

Drug Testing and Analysis · 2024

DOI: 10.1002/dta.3609 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Testing and Analysis, 2024. Verfasst von Caitlyn Norman und 15 weiteren Autor:innen. Beteiligte Einrichtung: Leverhulme Research Centre for Forensic Science, School of Science and Engineering, University of Dundee, Dundee, UK. Hauptthemen laut MEDLINE: Indazoles, Cannabinoid Receptor Agonists, Illicit Drugs, Substance Abuse Detection. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fonds Wetenschappelijk Onderzoek, Leverhulme Trust, National Institute of Justice.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synthetic cannabinoid receptor agonists (SCRAs) are a diverse class of new psychoactive substances (NPS) and new structural scaffolds have emerged on the recreational drug market since the enactment of Chinese SCRA analog controls in 2021. This study reports the first SCRAs to be detected with a bromide at the 5 position (5′Br) on the phenyl ring of the indazole core and without a tail moiety. ADB‐5′Br‐INACA (ADMB‐5′Br‐INACA) and MDMB‐5′Br‐INACA were detected in seized samples from Scottish prisons, Belgian customs, and US forensic casework. The brominated analog with a tail moiety, ADB‐5′Br‐BUTINACA (ADMB‐5′Br‐BUTINACA), was also detected in Scottish prisons and US forensic casework. The metabolites of these compounds and the predicted compound MDMB‐5′Br‐BUTINACA were identified through incubation with primary human hepatocytes to aid in their toxicological identification. The bromide on the indazole remains intact on metabolites, allowing these compounds to be easily distinguished in toxicological samples from their non‐brominated analogs. Glucuronidation was more common for tail‐less analogs than their butyl tail‐containing counterparts. Forensic toxicologists are advised to update their analytical methods with the characteristic ions for these compounds, as well as their anticipated urinary markers: amide hydrolysis and monoOH at tert ‐butyl metabolites (after β‐glucuronidase treatment) for ADB‐5′Br‐INACA; monoOH at tert ‐butyl and amide hydrolysis metabolites for ADB‐5′Br‐BUTINACA; and ester hydrolysis metabolites with additional metabolites for MDMB‐5′Br‐INACA and MDMB‐5′Br‐BUTINACA. Toxicologists should remain vigilant to the emergence of new SCRAs with halogenation of the indazole core and tail‐less analogs, which have already started to emerge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndazolesCannabinoid Receptor AgonistsIllicit DrugsSubstance Abuse DetectionHumansHepatocytesCannabinoidsTandem Mass Spectrometry

Stichwörter der Autor:innen

brominated synthetic cannabinoid receptor agonistsforensic toxicologymetabolismnew psychoactive substancesprison seizures

Substanzen

IndazolesCannabinoid Receptor AgonistsIllicit DrugsCannabinoids

Autor:innen und Institutionen

  • Leverhulme Research Centre for Forensic Science, School of Science and Engineering, University of Dundee, Dundee, UK.
  • Department of Biomedical and Clinical Science, Division of Clinical Chemistry and Pharmacology, Linköping University, Linköping, Sweden.
  • Center for Forensic Science Research and Education, Fredric Rieders Family Foundation, Willow Grove, Pennsylvania, USA.
  • Indianapolis-Marion County Forensic Services Agency, Indianapolis, Indiana, USA.
  • Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.
  • Chiron AS, Trondheim, Norway.

ORCID-Profile: Caitlyn Norman, Claude Guillou, Niamh NicDaéid, Christophe P Stove, Henrik Gréen

Förderung

  • Fonds Wetenschappelijk Onderzoek
  • Leverhulme Trust
  • National Institute of Justice
  • Sweden's Innovation Agency
  • European Commission
  • European Union's Horizon 2020
  • Linköping University
  • Scottish Prison Service

Zitieren

APA

Norman, C., Webling, K., Kyslychenko, O., Reid, R., Krotulski, A. J., Farrell, R., Deventer, M. H., Liu, H., Connolly, M. J., Guillou, C., Vinckier, I. M. J., Logan, B. K., NicDaéid, N., McKenzie, C., Stove, C. P., & Gréen, H. (2024). Detection in seized samples, analytical characterization, and in vitro metabolism of the newly emerged 5‐bromo‐indazole‐3‐carboxamide synthetic cannabinoid receptor agonists. Drug Testing and Analysis. https://doi.org/10.1002/dta.3609

Vancouver

Norman C, Webling K, Kyslychenko O, Reid R, Krotulski AJ, Farrell R, et al. Detection in seized samples, analytical characterization, and in vitro metabolism of the newly emerged 5‐bromo‐indazole‐3‐carboxamide synthetic cannabinoid receptor agonists. Drug Testing and Analysis. 2024. doi:10.1002/dta.3609

BibTeX
@article{Norman2024,
  author = {Norman, Caitlyn and Webling, Kristin and Kyslychenko, Oleksandra and Reid, Robert and Krotulski, Alex J and Farrell, Ryan and Deventer, Marie H and Liu, Huiling and Connolly, Matthew J and Guillou, Claude and Vinckier, Inge M J and Logan, Barry K and NicDaéid, Niamh and McKenzie, Craig and Stove, Christophe P and Gréen, Henrik},
  title = {Detection in seized samples, analytical characterization, and in vitro metabolism of the newly emerged 5‐bromo‐indazole‐3‐carboxamide synthetic cannabinoid receptor agonists},
  journal = {Drug Testing and Analysis},
  year = {2024},
  doi = {10.1002/dta.3609}
}
Kostenlos starten →